On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis drug bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped from $400 to $340 for a six-month treatment regimen.
With corona virus (COVID-19) spreading globally, IDA Foundation is closely monitoring the developments to ensure we are able to respond to any changes. This past week, we were glad to support the Asian Infrastructure Investment Bank (AIIB) by supplying medical goods to be used in the corona virus response in China.
As procurement agent for Stop TB /GDF, we are glad to share this news update as announced by the Stop TB partnership during the 50th Union Conference for Lung Health in Hyderabad, India.
IDA Foundation attended the Portage Inaugural Meeting in Centro Sharjah, UAE. The meeting aims to discuss ways to simplify treatment and access for Children with Cancer in low and middle income countries.